advertisement
Abstract #125201 Published in IGR 25-2
Synergistic AI-resident approach achieves superior diagnostic accuracy in tertiary ophthalmic care for glaucoma and retinal disease
Camacho-García-Formentí D; Baylón-Vázquez G; Arriozola-Rodríguez K; Avalos-Ramirez E; Hartleben-Matkin C; Valdez-Flores H; Hodelin-Fuentes D; Noriega AFrontiers in ophthalmology 2025; 5: 1581212
INTRODUCTION: Artificial intelligence (AI) shows promise in ophthalmology, but its potential in tertiary care settings in Latin America remains understudied. We present a Mexican AI-powered screening tool and evaluate it against first-year ophthalmology residents in a tertiary care setting in Mexico City. METHODS: We analyzed data from 435 adult patients undergoing their first ophthalmic evaluation using an AI-based platform and first-year ophthalmology residents. The platform employs an Inception V3-based multi-output classification model with 512 × 512 input resolution to capture small lesions when detecting retinal disease. To evaluate glaucoma suspects, the system uses U-Net models that segment the optic disc and cup to calculate cup-to-disc ratio (CDR) from their vertical heights. The AI and resident evaluations were compared with expert annotations for retinal disease, CDR measurements, and glaucoma suspect classification. In addition, we evaluated a synergistic approach combining AI and resident assessments. RESULTS: For glaucoma suspect classification, AI outperformed residents in accuracy (88.6% vs. 82.9%, = 0.016), sensitivity (63.0% vs. 50.0%, = 0.116), and specificity (94.5% vs. 90.5%, = 0.062). The synergistic approach achieved a higher sensitivity (80.4%) than ophthalmic residents alone or AI alone ( 0.001). AI's CDR estimates showed lower mean absolute error (0.056 vs. 0.105, 0.001) and higher correlation with expert measurements ( = 0.728 vs. = 0.538). In the retinal disease assessment, AI demonstrated higher sensitivity (90.1% vs. 63.0% for medium/high risk, 0.001) and specificity (95.8% vs. 90.4%, 0.001). Furthermore, differences between AI and residents were statistically significant across all metrics. The synergistic approach achieved the highest sensitivity for retinal disease (92.6% for medium/high risk, 100% for high risk). DISCUSSION: AI outperformed first-year residents in key ophthalmic assessments. The synergistic use of AI and resident assessments showed potential for optimizing diagnostic accuracy, highlighting the value of AI as a supportive tool in ophthalmic practice, especially for early career clinicians.
Tech & Intelligence Department, PROSPERiA, Mexico City, Mexico.
Full article